OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dipeptidyl-peptidase-4 inhibitors in type 2 diabetes and COVID-19: From a potential repurposed agent to a useful treatment option
Awadhesh Kumar Singh, Ritu Singh
Journal of Diabetology (2020) Vol. 11, Iss. 3, pp. 131-131
Open Access | Times Cited: 8
Awadhesh Kumar Singh, Ritu Singh
Journal of Diabetology (2020) Vol. 11, Iss. 3, pp. 131-131
Open Access | Times Cited: 8
Showing 8 citing articles:
COVID-19 and Diabetes
Awadhesh Kumar Singh, Kamlesh Khunti
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 129-147
Closed Access | Times Cited: 80
Awadhesh Kumar Singh, Kamlesh Khunti
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 129-147
Closed Access | Times Cited: 80
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, et al.
Future Virology (2023) Vol. 18, Iss. 5, pp. 321-333
Open Access | Times Cited: 20
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, et al.
Future Virology (2023) Vol. 18, Iss. 5, pp. 321-333
Open Access | Times Cited: 20
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations
André Scheen
Diabetes & Metabolism (2020) Vol. 47, Iss. 2, pp. 101213-101213
Open Access | Times Cited: 43
André Scheen
Diabetes & Metabolism (2020) Vol. 47, Iss. 2, pp. 101213-101213
Open Access | Times Cited: 43
Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
Awadhesh Kumar Singh, Ritu Singh, Banshi Saboo, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 15, Iss. 1, pp. 159-167
Open Access | Times Cited: 34
Awadhesh Kumar Singh, Ritu Singh, Banshi Saboo, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 15, Iss. 1, pp. 159-167
Open Access | Times Cited: 34
Using TransR to enhance drug repurposing knowledge graph for COVID-19 and its complications
Hongxi Zhao, Hongfei Li, Qiaoming Liu, et al.
Methods (2023) Vol. 221, pp. 82-90
Closed Access | Times Cited: 5
Hongxi Zhao, Hongfei Li, Qiaoming Liu, et al.
Methods (2023) Vol. 221, pp. 82-90
Closed Access | Times Cited: 5
Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design
Sayyed Abbas Tabatabai, Hanieh Maleksabet, Elham Rezaee
Current Pharmaceutical Design (2022) Vol. 28, Iss. 45, pp. 3583-3591
Closed Access | Times Cited: 5
Sayyed Abbas Tabatabai, Hanieh Maleksabet, Elham Rezaee
Current Pharmaceutical Design (2022) Vol. 28, Iss. 45, pp. 3583-3591
Closed Access | Times Cited: 5
Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19
Faruque Pathan, Shahjada Selim, Md Fariduddin, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 2217-2228
Open Access | Times Cited: 5
Faruque Pathan, Shahjada Selim, Md Fariduddin, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 2217-2228
Open Access | Times Cited: 5
Management of coronavirus disease-2019 (COVID-19) in patients with diabetes
Dhanasekaran Bodhini, Viswanathan Mohan
Journal of Diabetology (2020) Vol. 11, Iss. 3, pp. 125-125
Open Access
Dhanasekaran Bodhini, Viswanathan Mohan
Journal of Diabetology (2020) Vol. 11, Iss. 3, pp. 125-125
Open Access
